ABIOMED. A Company With Heart. Want One?

AUGUST 6, 2018. No one out-performs Amazon.
Or do they? ABIOMED is a company with heart. They make them–temporary percutaneous mechanical circulatory support devices. If you’re one of the many people with any of a variety of cardiac issues, this company may just help you heal. That’s whet CEO and President Michael Monogue will tell you.
Abiomed’s blood pumps create blood flow when the heart needs assistance. It’s ABMD’s time as well.
Born in 1997 this Danvers Mass-based company originally sought the artificial heart, a pedigree continuing to provide both direction and inspiration. That tight focus clearly shows in the financial metrics ABMD is now producing. There’s heart here, and it’s early days. Continue reading ABIOMED. A Company With Heart. Want One?

Google. Cash Swarm.

JULY 26, 2018. Smack talking about Google or Amazon is like dangling some stamped pot-medal chandelier in the ballroom of Wayne Manor. Nice. The Joker–oops, we mean Elizabeth Warren, seems to feel that the squeaky-clean European Commission is all good using Google like a cash machine. $2.7 billion last year and $5.01 billion this month. Very nice.
Perhaps the truly laudable senior senator from Massachusetts should focus on the CFPB, or EU Airbus subsidies.
Meanwhile, Batman–oops, Alphabet, soars to all-time highs off the glory of a monster $11.75 EPS score. The consensus estimate was $9.58.
What do you say when an $870b. company cranks out a retina-detaching 23% revenue growth rate, in constant currency terms, after turning 20? What do you say about Alphabet’s obscene cash mountain? Well, you say “Sorry for the smack–we love you.
Where’s the buy counter?” Continue reading Google. Cash Swarm.

Summer Blockbusters. The Very Best, In Bright Light.

JUNE 25, 2018. Myths die hard, or never. Here’s one.
The real winners are a secret, waiting for you to discover them. Not really. So why beat the weeds for that rare gem?
Secret stocks are the ones Wall Street never talks about. Guess what? If Wall Street doesn’t talk about them, they’re likely not worth your time. Again, why?
No doubt the equity investing world harbors stocks that are doing well, in near perfect darkness. Yet simple reasons exist for not beating the ditches to find such unusual names. How about your time? Instead of sifting the obscure for a great hope, simply follow the spotlight. The light is where things grow. Summer blockbusters you can grow with. Continue reading Summer Blockbusters. The Very Best, In Bright Light.